Biodexa Pharmaceuticals (NASDAQ:BDRX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Biodexa Pharmaceuticals (BDRX) operate in?

Biodexa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Biodexa Pharmaceuticals Stock (NASDAQ: BDRX) stock price, news, charts, stock research, profile.

Open	$4.71
Close	-
Volume / Avg.	1.47K / 156.96K
Day Range	$4.71 - $4.72
52 Wk Range	4.70 - 220.25
Market Cap	$74.06M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	0.09%
Days to Cover	1

Recent News

Why Is Brain Cancer-Focused Biodexa Pharmaceuticals Stock Trading Lower On Thursday?

Biodexa Pharmaceuticals reports updates from the MAGIC-1 study on MTX110 for recurrent glioblastoma. MTX110 has also demonstrated potential in treating diffuse midline glioma, a rare brain cancer, with significant improvements in survival rates in Phase 1 trials.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.71
Close	-
Volume / Avg.	1.47K / 156.96K
Day Range	$4.71 - $4.72
52 Wk Range	4.70 - 220.25
Market Cap	$74.06M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	0.09%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Biodexa Pharmaceuticals (BDRX) stock?

You can purchase shares of Biodexa Pharmaceuticals (NASDAQ:BDRX) through any online brokerage.

View our list of the best stock brokerages

Who are Biodexa Pharmaceuticals (BDRX) competitors?

Other companies in Biodexa Pharmaceuticals’s space includes: CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Cellectar Biosciences (NASDAQ:CLRB), Monopar Therapeutics (NASDAQ:MNPR) and Aligos Therapeutics (NASDAQ:ALGS).

What is the forecast, or price target, for Biodexa Pharmaceuticals (BDRX) stock?

Biodexa Pharmaceuticals has a consensus price target of $8.00.

What is the current price for Biodexa Pharmaceuticals (BDRX)?

The stock price for Biodexa Pharmaceuticals (NASDAQ: BDRX) is $4.71 last updated November 15, 2024 at 9:45 AM EST.

Does Biodexa Pharmaceuticals (BDRX) pay a dividend?

There are no upcoming dividends for Biodexa Pharmaceuticals.

When is Biodexa Pharmaceuticals (NASDAQ:BDRX) reporting earnings?

Biodexa Pharmaceuticals’s H1 earnings are confirmed for Tuesday, November 26, 2024.

Is Biodexa Pharmaceuticals (BDRX) going to split?

There is no upcoming split for Biodexa Pharmaceuticals.

What sector and industry does Biodexa Pharmaceuticals (BDRX) operate in?

Biodexa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Biodexa Pharmaceuticals

Biodexa Pharmaceuticals (BDRX) Forecast